Litcius/Paper detail

Duration of fracture prevention after zoledronate treatment in women with osteopenia: observational follow-up of a 6-year randomised controlled trial to 10 years

Ian R. Reid, Anne Horne, Borislav Mihov, Usha Bava, Angela Stewart, Gregory D. Gamble

2024The Lancet Diabetes & Endocrinology19 citationsDOI

Topics & Concepts

MedicineOsteopeniaObservational studyOsteoporosisFemoral neckRandomized controlled trialPhysical therapyPediatricsBone mineralInternal medicineBone health and osteoporosis researchParathyroid Disorders and TreatmentsConnective tissue disorders research
Duration of fracture prevention after zoledronate treatment in women with osteopenia: observational follow-up of a 6-year randomised controlled trial to 10 years | Litcius